Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma Immunotherapy

21 Feb 2023

Abstract excerpt

In this study, we put together a list of potentially the most beneficial bacteria that were associated with a responsiveness to melanoma immunotherapy. Another important result of this study is the list of functional biomarkers of responsiveness to immunotherapy, which are dispersed among different bacterial species. This result possibly explains the existing irregularities between studies regarding the bacterial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cutaneous Melanoma Detection and Management
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36809182
DOI: 10.1128/msystems.01023-22

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Consistent Stool Metagenomic Biomarkers Associated with the Response To Melanoma ImmunotherapyPMID 36809182Read ↗

Reproducible stool metagenomic biomarkers linked to the melanoma immunotherapy positive outcomeSemantic proximity Read ↗

Melanoma and microbiota: Current understanding and future directionsSemantic proximity Read ↗

Systemic metabolic depletion of gut microbiome undermines responsiveness to melanoma immunotherapySemantic proximity Read ↗

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomesSemantic proximity Read ↗

Taxonomy-free fecal microbiome profiles enable robust prediction of immunotherapy response and toxicity in melanomaSemantic proximity Read ↗

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic targetSemantic proximity Read ↗

Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway InhibitionSemantic proximity Read ↗

Roles of microbiota in response to cancer immunotherapySemantic proximity Read ↗

The gut microbiome and melanoma: A reviewSemantic proximity Read ↗

A review on the role of gut microbiota in immune checkpoint blockade therapy for cancerSemantic proximity Read ↗

Systemic Metabolic Depletion of Intestine Microbiome Undermines Melanoma Immunotherapy EffectivenessSemantic proximity Read ↗

Gut microbiome in modulating immune checkpoint inhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.